Dr. Rachel Bonami is an Assistant Professor of Medicine in the Division of Rheumatology
and Immunology at Vanderbilt University Medical Center. She is jointly appointed as an Assistant Professor of Pathology, Microbiology, and Immunology. She earned her Ph.D. in Microbiology and Immunology from Vanderbilt University in 2009. Her research program focuses on identifying autoantigen-specific B cells to define their phenotypic and functional attributes in people at risk for type 1 diabetes, patients with rheumatic diseases (with focus on the idiopathic inflammatory myopathies), and patients who develop autoimmunity following immune checkpoint inhibitor therapy for cancer. Her team works to develop approaches to harness autoreactive B cells as more selective biomarkers and identify pathways to target autoreactive B-cell survival and function.
Dr. Rachel Bonami is an Assistant Professor of Medicine in the Division of Rheumatology
and Immunology at Vanderbilt University Medical Center. She is jointly appointed as an Assistant Professor of Pathology, Microbiology, and Immunology. She earned her Ph.D. in Microbiology and Immunology from Vanderbilt University in 2009. Her research program focuses on identifying autoantigen-specific B cells to define their phenotypic and functional attributes in people at risk for type 1 diabetes, patients with rheumatic diseases (with focus on the idiopathic inflammatory myopathies), and patients who develop autoimmunity following immune checkpoint inhibitor therapy for cancer. Her team works to develop approaches to harness autoreactive B cells as more selective biomarkers and identify pathways to target autoreactive B-cell survival and function.